Mast Cell Changes the Phenotype of Microglia via Histamine and ATP

Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 17 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype Mast Cell Changes the Phenotype of Microglia via Histamine and ATP María Pilar Ramírez-Poncea Alejandro Sola-Garcíaa Santiago Balseiro-Gómeza,b María Dolores Maldonadoc Jorge Acostaa Eva Alésa Juan Antonio Floresa,c aDepartamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain, bDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA, cDepartamento de Bioquímica Médica y Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain Key Words Exocytosis • Phagocytosis • Histamine • ATP • Mast cells • Microglia Abstract Background/Aims: Microglia are the dynamic motile phagocytes of the brain considered the first line of defense against threats or disturbances to the Central Nervous System (CNS). Microglia help orchestrate the immunological response by interacting with others immune cells. Mast cells (MCs) are effector cells of the innate immune system distributed in all organs and vascularized tissues, brain included. Several molecular mechanisms for potential interactions between MCs and microglia have been determined. However, the effect of MCs on regulated exocytosis and phagocytic clearance in microglia has not been explored. Methods: Cocktails of MCs mediators (MCM) obtained at 37°C and 53°C were used to induce microglia activation. Changes in intracellular calcium [Ca2+]i and ATP release were studied by calcium and quinacrine fluorescence imaging. Fluorescent latex beads were used to assay phagocytosis in microglia after MCM treatment and compared to that measured in the presence of histamine, ATP and lipopolysaccharide (LPS). Iba-1 expression and area were quantified by immunofluorescence and histamine levels evaluated by ELISA techniques. Results: Local application onto microglia of the MC mediator cocktail elicited Ca2+ transients and exocytotic release associated with quinacrine dye de-staining. Ca2+ signals were mimicked by histamine and blocked by the H1 receptor (H1R) antagonist, cetirizine. Hydrolysis of ATP by apyrase also affected Ca2+ transients to a lesser extent. Iba-1 fluorescence, cell area and phagocytosis were enhanced by histamine through H1R. However, ATP prevented iba-1 expression and microglial phagocytosis. MCM showed combined effects of histamine and ATP, increasing the number of internalized microbeads per cell and area without raising iba1 expression. Conclusion: Our results highlight the relevance of MC-derived histamine and ATP in the modulation of secretory and phagocytic activities that would explain the heterogeneity of microglial responses in different pathological contexts. Original Paper Accepted: 29 December 2020 This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. DOI: 10.33594/000000324 Published online: 15 January 2021 © 2021 The Author(s) Published by Cell Physiol Biochem Press GmbH&Co. KG, Duesseldorf www.cellphysiolbiochem.com © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Eva Alés Departamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad of Sevilla, Av. Sánchez Pizjuán 4, Sevilla 41009 (Spain) Tel. +34 954559868, E-Mail [email protected] Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 18 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype Introduction Chronic inflammation in CNS is a hallmark of neurodegenerative disorders in which progressive loss of neurons and altered physicochemical properties in the brain are observed [1, 2]. Microglia cells, key players in such disorders, are the resident macrophages of the brain and play an important role in maintaining normal brain function. Pathological states within the nervous system can lead to microglial activation, characterized by morphological changes, proliferation, and migration towards the injury site; phagocytosis; and secretion of various cytokines, chemokines, and other inflammatory mediators [3]. Activation of microglial cells can result in different phenotypes and roles (neurotoxic or neuroprotector) with versatile actions and variable responses depending on the stimulus intensity and context [4]. In their resting state, microglial cells display a ramified morphology characterized by numerous, fine-branched processes with relatively small bodies. When activated in response to injury or inflammatory stimuli, the resting microglia increase Ca2+ permeability that leads to Ca2+ influx into the cells. This increase of intracellular calcium [Ca2+]i acts as a versatile intracellular second messenger that initiates signaling cascades, leading to essential biological processes such as the morphological transformation [5] in which cells become progressively less ramified and quickly develop an ameboid appearance with an enlarged cell body and several short, thickened processes. Elevations of [Ca2+]i in microglial cells is also required in ATP and BDNF secretion through Ca2+ dependent exocytosis from lysosomes and secretory granules [6, 7]. Given the involvement of lysosomal secretion in cytokine release [8, 9], the exocytotic process can be crucial to define the phenotype acquired by these plastic cells upon activation. In addition, microglial functions such as motility and phagocytosis are closely associated with dynamic changes in the cytoskeleton and related to intracellular calcium signaling [10, 11]. Microglia can respond to pro-inflammatory signals released from other non-neuronal cells of immune origin, which include mast cells (MCs). These cells reside in the brain and can traverse the blood-brain barrier in healthy and pathological conditions [12, 13]. MCs contain numerous secretory granules that hold a wide spectrum of mediators, including biogenic amines such as histamine and serotonin, enzymes, ATP, neuropeptides and proteoglycans [14]. In addition to rapid mediator release of preformed granule constituents via degranulation, longer-term activation results in the release of the novo formed mediators such as lipid mediators and cytokines [15]. Brain MCs are activated in CNS disorders and induce the release of several mediators. MCs were reported to induce microglial activation and inflammatory mediator release [16, 17] suggesting a pivotal role of these cells in the induction of CNS inflammation. Thus, the suppression or stabilization of brain MCs degranulation can inhibit both microglial activation and CNS inflammation [18-20]. Mast cell-microglia communication contributes to accelerate disease progression. However, the functional consequences of MCs in microglial exocytosis and phagocytosis remain unexplored. Microglia activation is associated to secretion of several molecules, which either propagate inflammation and cause damage to neurons or play a neuroprotective role [21]. Microglia also phagocytizes foreign pathogens, apoptotic cells, myelin debris and released toxic proteins. In this study, we imaged changes in [Ca2+]i and, measured exocytosis of ATP-containing vesicles and the phagocytic activity of microglia evoked by a cocktail of MCs mediators. Our results suggest MC may trigger microglia activation that results in functional responses determined by the contribution mainly of histamine but also ATP. Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 19 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype Materials and Methods Cocktail of mast cells mediators A cocktail of mast cells mediators (Mast cells Conditioned Medium, MCM) was prepared as previously described [22]. Briefly, 1 x 106 purified MCs obtained after a 70% Percoll purification were resuspended in 1 ml of basal Locke solution containing 140 mM NaCl, 10 mM HEPES, 3 mM KOH, 2 mM CaCl2, 1 mM MgCl2, and 10 mM glucose (pH 7.3, adjusted with NaOH). Cells were placed into a prewarmed Thermomixer (Eppendorf) for 1h at 53°C with moderate agitation (600 rpm). MC degranulation was verified by visual inspection under a microscope. The MCM was obtained from the supernatant after centrifugation of MCs solution at 200xg for 5 min. Supernatant was aliquoted (50 μl) and stored at −80°C until use. MCM from MCs kept at 37°C, 5% CO2 for 1 h was obtained to evaluate the degree of degranulation in basal conditions. Enzyme-Linked Immuno-Sorbent Assay (ELISA) The expression of histamine levels in MCM was quantified with a commercial ELISA kit from Beckman Coulter (IMMUNOTECH – Prague, Czech Republic) following the manufacturer’s instructions. All samples were run in duplicate. Microglia-Enriched Cultures Isolated microglia were obtained using a mild trypsinization over mixed glial cultures as previously described [23] with slight modifications. Mixed glial cultures were prepared from cerebral cortices of postnatal (P2-P4) Wistar rats, which were subjected to mechanical dissociation. After filtering cells through a filter nylon mesh of 100 µm, the cells obtained were seeded in Dulbecco’s modified Eagle’s medium (DMEM)/F12 with 20% of inactivated foetal bovine serum (FBS) at a density of 300,000 cells/ml on 15 mm-diameter cover glass and maintained at 37°C in a humidified atmosphere of 5% CO2/95% air. Culture medium was replaced after 5 days in vitro (DMEM/ F12 and 10% of inactivated FBS). After reaching a confluent monolayer of glial cells (10-12 days), microgliaenriched cultures were obtained with a trypsin solution (0,05% trypsin and EDTA) diluted 1:4 in DMEM/ F12. This process resulted in the detachment of the upper layer of cells in one piece, while microglial cells remained attached on the surface of the cover glass. Mild trypsinization has been proved to be a reliable method to isolate microglia from mixed glial cultures with increased yield and purity, and microglial cells seem to be in an immune state closer to their resting state in comparison with the shaking method [24]. However, our cultures did not exceed 15% of cells with a resting phenotype. Recordings of [Ca2+]i signal Changes in [Ca2+]i of microglial cells in response to different stimuli were monitored by dual excitation microfluorimetry. Microglial cells were incubated in Locke external solution containing Fura-2 AM 5 µM (Molecular Probes) and pluronic F-127 0.004%, (Sigma) for 45 min at 37°C in the dark. Later, cells were washed twice in external solution without the dye and used for imaging. The cover glass with cells loaded with Fura-2 AM was then mounted in a RC-25F perfusion chamber (Warner instruments) and placed on the microscope (AxioVert 200, Zeiss). During recordings, microglial cells were excited by a xenon light source at 360/380-nm wavelengths (exposure time, 0.5 s; data acquisition at 0.33 Hz) by means of two narrow beam band-pass filters selected by a computer-controlled wheel. The emitted fluorescence was filtered through a 520-nm filter and captured with an ORCA-R2 CCD camera (Hamamatsu Photonics). Fura-2 AM loading was usually uniform over the cytoplasm, and dye compartmentalization was never observed. Data were acquired and stored using HCImage software and exported to Igor Pro (WaveMetrics) to perform analysis. All values were normalized to the basal fluorescence (baseline). The [Ca2+]i signal was expressed by the ratio of fluorescence at 360 nm and 380 nm. The agents used to stimulate microglia were MCM, histamine 100 µM, serotonin 100 µM and ATP 100 µM. When required, cells were incubated with cetirizine 1 µM, ranitidine 10 µM, carcinine 10 µM or A943931 10 µM, antagonists of H1R, H2R, H3R and H4R, respectively, or FSLLRY-NH2 (PAR2 antagonist) 400 µM for 10 min at 37°C before the application of MCM or histamine. MCM was treated with apyrase 50 U/ml for 10 min, chondroitinase ABC 50 mU/ml or heparinase 0.5 U/ml for 1 h at 37°C to evaluate the effect of ATP, chondroitin sulphate or heparin from the MCM on microglial cells, respectively. These products were applied through a pressure pulse (5 s) with a micropipette (1 µm diameter) positioned approximately 100 µm to the microglial cell. All experiments were performed at 37°C. Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 20 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype Imaging and analysis of Quinacrine dye release To visualize microglial acidic organelles, microglia was treated with 10 µM quinacrine in Locke external solution for 10 min at 37°C in the dark. Later, microglial cells were washed twice in external solution without the dye and used for imaging. The cover glass with cells loaded with quinacrine was then mounted and transfer to the chamber for imaging under an inverted microscope with a 63× PlanNeofluar (NA 1.3) oil immersion lens (Zeiss). The fluorescence images were collected every 5s, with excitation at 472 nm and emission at 579 nm. Data analysis was performed with HCImage software (Hamamatsu). Time-lapse imaging of quinacrine fluorescence was evaluated after application of MCM, histamine 100 µM, ATP 100 µM and LPS 1 µg/ml. Phagocytosis Assay and Microglia Immunofluorescence After mixed glia culture was subjected to trypsin treatment, microglial cells were allowed to recover for 24h, after which the cells were ready to undergo some microglial treatments for 48h. These treatments were as follows: control (without any treatment), MCM, 1µg/ml of LPS, 4 µM histamine, 100 µM histamine, 10 µM ATP and 100 µM ATP. When required, cells were incubated with cetirizine 1 µM, ranitidine 10 µM, carcinine 10 µM or A943931 10 µM. Later, we proceeded to the phagocytosis assay (blind experiments). This is as follows (with some modifications [25]). Fluorescent latex beads were used to assay phagocytosis. Fluorescent beads were pre-opsonized in non-inactivated FBS for 1h at 37°C. Ratio of beads to FBS was 1:5. Beads-containing FBS with DMEM/F12 with 10% of inactivated FBS were diluted to reach final concentrations for beads and FBS in DMEM/F12 of 0.01% (v/v) and 0.05% (v/v), respectively. Then, cell cultures were incubated with beads-containing medium at 37°C for 1h and washed thoroughly with ice-cold PBS 5 times. Next, cells were fixed using 4% PFA for 30 min at room temperature. After that, we performed iba-1 immunofluorescence. Firstly, cells were permeabilized with 0.1% Triton X-100 in PBS and, after adding blocking solutions for 1h at room temperature, incubated overnight with rabbit anti- Iba1 monoclonal antibody (1:1000) (Synaptic Systems) at 4°C. Cells were washed five times with PBS, then incubated with Alexa Fluor 555-conjugated goat anti-rabbit secondary antibody (1:500) (Molecular Probes) at room temperature for 1h. After this, cells were washed five times with PBS and mounted on cover glasses with Fluoromont-G medium. Fluorescent images were randomly acquired using an inverted microscope (AxioVert 200, Zeiss). To visualize the iba-1 staining, microglia were excited by a xenon light source at 552 nm wavelength (exposure time, 0.8 s); in the case of beads, these were excited with a FITC-filter at 495 nm (exposure time, 0.08 s). The emission wavelengths were 578 and 519 nm, respectively. For the study of the effects of MCM and the rest of treatments on the number of phagocytosed beads (mean ± S.E.M.), bead-labelled cells were counted in four separate culturing procedures under the microscope with a 40x objective (blind analysis). Microglial cell area and intensity were measured from iba-1 cell fluorescence images through automatic thresholding selection (HCImage). Statistical Analysis Statistical analyses were carried out with the Mann-Whitney Rank Sum test or the Student’s t test (SPSS Statistics 25). All measurements were expressed as mean ± standard error of the mean (SEM), and p≤ 0.05 was considered significant. Results MCM triggers calcium transients essentially in resting microglia In the present study, we stimulated cultured rat microglial cells with a pressure pulse (5 s) of MCM (Fig. 1A). This cocktail of MCs mediators obtained by heat (53°C, 1 h), showed a rapid and transient elevation of intracellular calcium ([Ca2+]i) in one out of two cells (167 out of 353 cells) measured by Fura-2 fluorescence (Fig. 1B, C). As MCs are temperature sensitive, the noxious physical stimuli (53°C) produced a clear degranulation verified by visual inspection under microscope (Supplementary Fig. 1B – for all supplementary material see www.cellphysiolbiochem.com). This strategy elicits MC degranulation and avoids the use of stimuli such as compound 48/80, antigens, complement proteins or neuropeptides which can also activate microglia themselves. Interestingly, MCM obtained at 37°C, was Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 21 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype also able to trigger intracellular Ca2+ elevation in 27% (6 out of 22) of microglial cells. At this temperature, MCs showed an intact appearance without clear degranulation (Fig. 1A Supplementary). The increase in intracellular Ca2+ evoked in microglial cells by MCM at 37°C was also transient and reached a peak of 0.23 ± 0.06 and area under curve (AUC) of 4.34 ± 1.12 that were similar to that induced by the MCM obtained by heat (53°C) (DF/F: 0.33 ± 0.01; AUC: 4.38 ± 0.24) (Fig. 1E, F). Microglial cells with a ramified morphology with long, thin processes and small cell bodies are the major responders to the MCM (80.2 % at 53°C and 100% at 37°C) (Fig. 1G, H). These cells exhibit shapes typical of resting microglia and a weaker iba1 signal, a microgliaspecific calcium-binding protein, in comparison with expression of iba1 in spindle, rod or amoeboid-shaped cells, corresponding to activated microglia (Fig. 1G). These data suggest that low secretion of mediators, such as the escape of biogenic amines from granules during basal activity of MCs (37°C) is sufficient to evoke Ca2+ elevations mainly in those microglial cells with a resting phenotype. All the experiments carried out below were performed with a MCM obtained after degranulation of MCs at 53°C to make sure full release of granule mediators. Fig. 1. Calcium imaging of microglial cells. A) Phase-contrast image of rat cultured microglia and a glass micropipette of 1µm φ connected to a picospritzer which applies 5 s pressure ejection (2.5 psi) pulses. B) Fluorescence image showing the same cells loaded with the Ca2+ sensitive dye Fura 2-AM. C) Representative trace of [Ca2+]i transient in a cell evoked by the application of MCM obtained after MCs degranulation at 53°C. D) Representative trace of [Ca2+]i transient in a cell evoked by application of MCM obtained after MCs incubation at 37°C. E) Mean [Ca2+]i peak and F) Area under curve (AUC) obtained in microglia-evoked responses by stimulation with MCM at 53°C and 37°C. G) Anti-Iba1 immunostaining of microglial cells with different morphological phenotype (2 resting cells with ramified long processes and rounded cell bodies (*) and 1 activated cell with an amoeboid appearance (arrow)). Left panel shows cells in brightfield, middle and right panels show fluorescence images taken at 60X and a 366 hV and 536 hV of gain, respectively. H) Percentage of microglia activated by MCM at 53°C and 37°C. Numbers inside the bars indicate the proportion of activated or resting cells that showed a [Ca2+]i transient after MCM application. Scale bar: 10 µm. Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 22 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype Histamine and ATP are the mediators involved in microglia evoked Ca2+ transient We investigated which mediators were involved in this Ca2+ signaling. MCs contain a wide array of chemical mediators that can be released to the extracellular medium. We focused on the preformed products contained within the granules. To elucidate which mediators were involved in the promotion of microglia activation, we first directly stimulated microglial cells with bioactive monoamines (histamine, serotonin) and ATP. The effects of histamine (100 µM) on Ca2+ signal in microglial cells were similar to those elicited by MCM at 53°C (Fig. 2A, B), with a 43% of response (83 out of 192 cells) (Fig. 2D) and, a [Ca2+]i peak and area under curve of 99.1 ± 0.6% and 121.2 ± 10.5 %, respectively (Fig. 2E, F). Histamine mostly affected intracellular Ca2+ of resting cells (81.9% of responding cells) in consonance with the effects observed with MCM (80.2% of cells). However, serotonin did not evoke any response. On the contrary, external application of ATP (100 µM) caused a Ca2+ transient (Fig. 2C) in most of the stimulated cells (94.8 %; 128 out of 135 cells) basically in activated microglia (70.9%) (Fig. 2D). In addition, while [Ca2+]i peak was not different (88.6 ± 6 %) (Fig. 2E), the area under the curve was significantly lower (62.8 ± 3.1 %) (Fig. 2F) in ATP than in MCM-stimulated cells. When the selective antagonist of the histamine H1 receptor, cetirizine, was incubated within the cell chamber, 10 min before the application of histamine, Ca2+ transient response was completely abolished (Fig. 2B, D). However, neither ranitidine 10 µM (H2R antagonist), carcinine 10 µM (H3R antagonist) nor A943931 10 µM (H4R antagonist) modified [Ca2+]i peak and area under the curve induced by histamine 100 μM (Supplementary Table 1). Cetirizine also suppressed microglial activation induced by MCM, although a small pool of cells was resistant to the drug (10.3%; 21 out of 203 cells) (Fig. 2A, D). On the other hand, apyrase, an enzyme that catalyzes ATP hydrolysis, dramatically reduced ATP-response to 15.7 % (8 out of 51 cells); however, it did not affect MCM-microglia response (69.8%; 43 out of 61 cells) (Fig. 2A, C, D). Moreover, while [Ca2+]i peak and the area under the curve were abruptly reduced in cells under ATP + Apyrase (DF/F: 12.5 ± 4.1%: AUC: 4.3 ± 1.7%), the effect of apyrase on microglia response mediated by MCM was smaller; [Ca2+]i peak was similar (107 ± 2.4 %), however, the area under the curve was lower (60.6 ± 10.7 %) than that obtained by application of MCM alone (Fig. 2E, F). Next, we selectively blocked PAR2 receptors with the antagonist FSLLRY-NH2 to determine the involvement of mast cell-specific proteases. We incubated cells for at least 10 min with FSLLRY-NH2 (400 µM) before proceeding to apply MCM. The drug barely modified [Ca2+]i signal evoked by MCM (DF: 107.5 ± 10.2%; AUC: 105.7 ± 8.6%; 38 out of 70 cells)(Fig. 3B, E, F). Lastly, to resolve the implication of highly anionic serglycin proteoglycans (PGs) containing glycosaminoglycan side chains of either heparin or chondroitin sulfate (CS) type in microglia activation, we incubated the MCM with heparinase or chondroitinase ABC for 1h at 37°C to break down the PGs of heparin and CS, respectively. Chondroitinase ABC did not change the peak amplitude and the area under the curve of [Ca2+]i transients in respect to untreated MCM (DF: 95.6 ± 9.25%; area under curve: 99.9 ± 9.1%; 16 out of 30 cells) (Fig. 3C,E,F). Similarly, heparinase neither reduced the amount of [Ca2+]i entry into the cell (DF: 78.5 ± 7.7%; area under curve: 106 ± 9.1%; 32 out of 55 cells) (Fig. 3D, E, F). All these data suggest histamine H1 receptor mostly contributes to intracellular Ca2+ elevation in cultured microglia mediated by MCs. To a lesser extent, ATP also contributes in shaping the Ca2+ transient. Because histamine is the key mediator to initiate Ca2+ signaling that triggers microglia activation, we measured histamine concentration of used cocktails. On average, histamine concentration from MCM obtained at 53°C (1 h) was 275 ± 90 µM and at 37°C (1h) of 17.5 ± 0.6 µM. Ca2+ dependent exocytosis in microglia stimulated by MCM and histamine ATP is considered the major chemokine attracting microglia towards the injured brain regions [26] and microglia release ATP in response to stimuli which trigger intracellular calcium elevation [27]. Here, we incubated cells with quinacrine (10 μM for 10 min at room temperature), a fluorescent marker for intracellular ATP-enriched vesicles used to examine Ca2+ dependent regulated exocytosis of ATP [6, 7]. We quantified exocytosis measuring Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 23 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype fluorescence changes of cells after stimulation with MCM for 30s through a micro-perfusion pipette. As a control, application of an external solution produced a variable but gradual loss of fluorescence signal in 65% of cells which can be attributed to spontaneous vesicle fusion with the plasma membrane and dispersal of its fluorescent cargo (Fig. 4A, B, E). However, application of MCM induced a more abrupt loss of fluorescence (Fig. 4C, D, F) in 90.3% of cells to a significantly larger extent (DF: 0.43 ± 0.02; n=113) than that observed in control cells (DF: 0.26 ± 0.04; n=40). Furthermore, stimulation with histamine 100 µM and LPS 1 µg/ ml also induced an important loss of fluorescence of 0.5 ± 0.04 and 0.49 ± 0.02, respectively, Fig. 2. Histamine and ATP contribute to outline the [Ca2+]i signal elicited by MCs mediator cocktail. A) [Ca2+]i signals evoked by single 5 s pressure ejection pulses of MCM alone (solid trace) and MCM applied after cetirizine (Cet) 1 µM (dotted line) and apyrase (Apy) 50 U/ml (dashed line) treatment (10 min). B) Representative [Ca2+]i signals evoked by histamine (HIS) 100 µM (solid line) and histamine 100 µM applied after cetirizine 1 µM (dotted line) treatment (10 min). C) Representative [Ca2+]i signals evoked by single pressure pulses of ATP 100 µM (solid line) and ATP 100 µM applied after apyrase 50 U/ ml treatment (10 min) (dashed line). D) Percentage of stimulated cells which displayed [Ca2+]i transients in response to the different treatments according to the observed phenotype (resting vs activated). E) [Ca2+]i signal amplitude (peak) and F) area under curve (AUC) obtained by application of MCM, histamine 100, histamine following incubation with cetirizine (HIS + Cet), serotonin (SER), ATP, ATP after incubation with apyrase (ATP + Apy), MCM after incubation with cetirizine (MCM + Cet) and MCM after incubation with apyrase (MCM + Apy) are presented as % of means ± SEM. Data were normalized regarding the MCM response. Statistically significant from MCM-treated cells (***p<0.001, **p<0.01). Statistically significant from ATP-treated cells (###p<0.001, ##p<0.01). Statistically significant from histamine-treated cells ($$$p<0.001), using Mann-Whitney Rank Sum test. Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 24 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype in more than 92% of cells (Fig. 4H). ATP did not increase significantly the exocytosis in 89.5% of cells affected by the nucleotide. Cells with an activated morphology prevail over those of resting phenotype when measuring exocytosis in all used treatments (Fig. 4G). These results suggest that despite few activated microglia were able to rise [Ca2+]i in response to MCM, the vast majority of them undergo exocytosis of quinacrine loaded-organelles, comparable to that observed by histamine or LPS. Microglia metamorphosis induced by the MCM As microglial activation is characterized by morphological changes and upregulation of the specific calcium-binding protein iba1, we analyzed the area and iba1-fluorescence in cells iba1-positive from control cells and cells treated during 48 h with MCM, histamine 4 and 100 µM, ATP 10 μM and 100 µM, and LPS 1 µg/ml. Histamine concentration of used MCM was 3.7 μM, obtained by dilution of the pure extract. For comparative purposes, we treated cells with histamine 4 μM in addition to histamine 100 µM. MCM showed a large increase in area (253.4 ± 12 µm2, n=372) in respect to control cells (154.9 ± 5 µm2, n=1117) (Fig. 5A, B) Histamine 4 µM (HIS 4) and 100 µM (HIS 100) also showed an increase in area (170.1 ± 8 µm2, n=605 and 175.4 ± 7 µm2, n=354, respectively) although lower to that observed by MCM. LPS did not show an increment of area (155 ± 9 µm2, n=215) in respect to control cells. Finally, ATP 10 μM showed an increase of area (200.8 ± 6 µm2, n=355) in respect to control cells as well as ATP 100 μM (216.1 ± 8 µm2, n=495) (Fig. 5A, B). On the other hand, the effect of the cocktail of mediators did not change iba1 intensity (61.8 ± 1.5) in respect to control cells (62.5 ± 1.5) (Fig. 5C) but both histamine concentrations increased iba-1 expression (HIS 4: 70.8 ± 1.6; HIS 100: 69.6 ± 1.4). The higher increment was obtained with LPS (82.6 ± 3.5). ATP reduced iba1 intensity at 10 µM (56.8 ± 1.4) and 100 μM (53.8 ± 1.5). Overall, results on area and iba-1 expression by MCM on microglia may be the consequence of the summatory Fig. 3. PGs of CS and heparin, and proteases did not contribute to outline the [Ca2+]i signal elicited by mast cells mediator cocktail. A) Trace illustrating a control MCM-evoked response. B) The response did not change after incubation with FSLLRYNH2. C) Neither pre-digestion of MCM with chondroitinase ABC nor D) heparinase modified [Ca2+]i transients. E) [Ca2+]i signal amplitude (peak) and F) area under curve (AUC) are presented as % of means ± SEM. Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 25 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype effects induced by ATP and histamine present in the MCM. MCM showed a potentiation of the area enlargement observed by histamine and ATP. Changes of iba-1 expression in the presence of ATP and histamine are similar but in the opposite sign, therefore the outcome of both combined mediators in the MCM may be the absence of modification in this parameter. The phagocytotic phenotype of microglia is determined by histamine Phagocytosis was assessed by using fluorescent latex beads of 1µm diameter under the same conditions and incubation intervals as above. MCM (≈ 4 µM histamine), histamine 4 µM and 100 µM showed an increase in the engulfment of microspheres per cell (MCM: 2.91 ± 0.3, n=393; HIS 4: 2.71 ± 0.24, n=639; HIS 100: 3.08 ± 0.27, n=544) regarding control cells (2.08 ± 0.13, n=1291) (Fig. 6A, B). Histamine 20 µM was also used (2.98 ± 0.31) and it did not show Fig. 4. Changes in fluorescence intensity of quinacrine-loaded cells during exocytosis. A) Example image of quinacrine loaded microglia cells before and B) ∼5 min after application of external solution by microperfusion (control experiment). C) Example image of quinacrine loaded microglia cells before and D) ∼5 min after application of MCM. A larger loss of fluorescence was observed in respect to control. E) Time courses of fluorescence changes (normalized) in control cells and F) MCM treated cells from the upper images. G) Percentage of microglial cells (resting versus activated) that showed a positive exocytotic response (fluorescence decay >5% FINITIAL) following stimulation with MCM, histamine (HIS), ATP, and LPS. H) Amplitude (DF) measured from fluorescence curves (FINITIAL – FFINAL). Data represent average values of at least three independent culturing experiments. ***p<0.001, using the Mann- Whitney Rank Sum test. Scale bar 5 µm. Cell Physiol Biochem 2021;55:17-32 DOI: 10.33594/000000324 Published online: 15 January 2021 32 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG Ramirez-Ponce et al.: Mast Cell Changes Microglia Phenotype 37 Kempuraj D, Selvakumar GP, Thangavel R, Ahmed ME, Zaheer S, Raikwar SP, et al.: Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer’s Disease Pathogenesis. Front Neurosci 2017;11:703. 38 Hendriksen E, van Bergeijk D, Oosting RS, Redegeld FA: Mast cells in neuroinflammation and brain disorders. Neurosci Biobehav Rev 2017;79:119–133. 39 Niederhoffer N, Levy R, Sick E, Andre P, Coupin G, Lombard Y, et al.: Amyloid β Peptides Trigger CD47- Dependent Mast Cell Secretory and Phagocytic Responses. Int J Immunopathol Pharmacol 2009;22:473– 483. 40 Harcha PA, Vargas A, Yi C, Koulakoff AA, Giaume C, Sáez JC: Hemichannels are required for amyloid β-Peptide-induced degranulation and are activated in brain mast cells of APPswe/PS1dE9 Mice. J Neurosci 2015;35:9526–9538. 41 Majumdar A, Cruz D, Asamoah N, Buxbaum A, Sohar I, Lobel P, et al.: Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol Biol Cell 2007;18:1490–1496. 42 Fu R, Shen Q, Xu P, Luo JJ, Tang Y: Phagocytosis of microglia in the central nervous system diseases. Mol Neurobiol 2014;49:1422–1434. 43 Tremblay M-E, Cookson MR, Civiero L: Glial phagocytic clearance in Parkinson’s disease. Mol Neurodegener 2019;14:16. 44 Flores JA, Balseiro-Gómez S, Ales E: Emerging Roles of Granule Recycling in Mast Cell Plasticity and Homeostasis. Crit Rev Immunol 2016;36:461–484.